Short-term: Key measurements of effect (measured at T1 and T2 in Groups A and B)
|
Self efficacy
|
The Self-Efficacy for Managing Chronic Disease (SEM-CD) scale (6 items) developed by the Stanford Patient Education Research Center [67].
|
Empowerment
|
Proxy of “The Health Education Impact questionnaire (heiQ)” [77]
|
Comorbidity
|
The Disease Burden Morbidity assessment (DBMA) [64]
|
Mid-term: Key measurements of effect (measured at T1 and T3 in Groups A and C)
|
Health behaviour
|
Behaviour Risk Factor Survey System Questionnaire (eating habits, physical activity, smoking and alcohol consumption) [65]
|
Functional health status/quality of life
|
SF -12 [63,78]
|
Psychological well-being
|
K-6 [62]
|
Comorbidity
|
The Disease Burden Morbidity Assessment (DBMA) [64]
|
Other variables
|
Participant characteristics
|
Sex, age, socioeconomic status, education, referral diagnosis
|
Co-intervention |
Questionnaire on co-interventions |